Calithera Biosciences, Inc.
CALADelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001496671
Calithera Biosciences, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on May 26, 2023; 29 institutions reported holding it in 13F filings for Q2 2022, worth $4.44M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Calithera Biosciences, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 100 | 77 | −23 |
| Shares | 52.6M | 46.9M | −5.71M (−10.9%) |
| Value | $127.3M | $99.0M | −$28.3M (−22.3%) |
New holders (14)
Institutions that held Calithera Biosciences, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Assenagon Asset Management S.A. | 350,806 | $733.0K | 0.00% |
| Ergoteles LLC | 300,900 | $629.0K | 0.01% |
| Bridgeway Capital Management, LLC | 300,000 | $627.0K | 0.01% |
| HRT Financial LP | 190,219 | $397.0K | 0.00% |
| Tibra Equities Europe Ltd | 158,500 | $331.0K | 0.10% |
| QS Investors, LLC | 133,200 | $279.0K | 0.00% |
| Parkman Healthcare Partners LLC | 100,628 | $210.0K | 0.05% |
| Acadian Asset Management LLC | 40,544 | $85.0K | 0.00% |
| Strategic Wealth Advisors Group, LLC | 40,600 | $85.0K | 0.00% |
| LMR Partners LLP | 35,136 | $73.0K | 0.00% |
| Citadel Advisors LLC | 27,429 | $57.0K | 0.00% |
| Tarbox Family Office, Inc. | 21,000 | $44.0K | 0.01% |
| Boothbay Fund Management, LLC | 19,097 | $40.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 16,387 | $34.0K | 0.01% |
Sold out (37)
Institutions that held Calithera Biosciences, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.